drugset / Trial / NCT01220024
Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will assess pain intensity for the first 72 hrs after after aggravated movement (cough)following open laparotomy inguinal herniorrhaphy in patient who receive either the CollaRx Bupivacaine implant or a plain collagen sponge.
Timeline
- Start
- 2010-12-02
- Primary completion
- 2011-05-18
- Completion
- 2011-05-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 200 mg | Other |
Indications
No indication recorded.